NCT02593565 · University of Pennsylvania
Vasculitis Pregnancy Registry
(V-PREG)
What this study is about
The purpose of this study is to learn about the experience of women with vasculitis who become pregnant. In particular, the study will consist of several online surveys to assess 1. each woman's vasculitis severity and pregnancy-related experiences, and 2. pregnancy outcomes.
View original scientific description
The purpose of this study is to learn about the experience of women with vasculitis who become pregnant. In particular, the study will consist of several online surveys to assess 1. each woman's vasculitis severity and pregnancy-related experiences, and 2. pregnancy outcomes.
Interventions
OTHER
Online questionnaires
Women will be asked to complete questionnaires during their pregnancy and a postpartum questionnaire.
Primary outcome measures
Unique pregnancy characteristics among women with vasculitis.
Time frame: Four years
To understand pregnancy characteristics and outcomes among women with vasculitis using patient-reported questionnaires in each trimester.
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- Women 18 years of age or older with one of the following diseases may take part in the study:
- Behçet's disease;
- Central nervous system (CNS) vasculitis;
- Cryoglobulinemic vasculitis (Cryoglobulinemia);
- Eosinophilic granulomatosis with polyangiitis (also called Churg-Strauss Syndrome);
- Giant Cell (Temporal) Arteritis (GCA);
- Granulomatosis with polyangiitis (also called Wegener's);
- IgA vasculitis (Henoch-Schoenlein purpura);
- Microscopic polyangiitis (MPA);
- Polyarteritis nodosa (PAN);
- Takayasu's arteritis (TAK);
- Urticarial vasculitis;
- Other/Suspected Diagnosis.
- Women must be pregnant (self-report) at the time of enrollment into the registry.
Exclusion criteria
- Non-English speaking, with the exception of people who speak Spanish, Portuguese, Italian, or Turkish.
- Unable to provide consent.
Where
- Tampa, Florida
Collaborators
Duke University, University of South Florida
Related conditions & keywords
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced Jan 23, 2026 · Source of record for eligibility and locations